Morphological analysis of squamous cells in routine Pap smears as a predictor of bone mineral density in asymptomatic women

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 113, Issue 2, 2004, Pages 221-225

  Repše Fokter, Alenka ^a   Fokter, Samo K ^a   Komadina, Radko ^a   Štiblar Martinic, Draga ^b   Takac, Iztok ^c  

^a General Hospital Celje   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c UNIVERSITY MEDICAL CENTRE MARIBOR   (Slovenia)

Author keywords

Astereology; Bone mineral density; Cervical cancer screening; Densitometry; Osteoporosis; Pap smear

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; ASTEREOLOGY; BONE DENSITY; BONE MINERAL; CANCER SCREENING; CELL MATURATION; CELL NUCLEUS; CELL STRUCTURE; CONTROLLED STUDY; CYTOPLASM; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MEASUREMENT; MICROMORPHOLOGY; PAPANICOLAOU TEST; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM; SQUAMOUS CELL; STATISTICAL SIGNIFICANCE; SYMPTOM; TECHNIQUE;

EID: 1842454333     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2003.09.028     Document Type: Article

References (20)

1. Melton L.J. III, Chrischilles E.A., Cooper C., Lane A.W., Riggs B.L. Perspective, how many women have osteoporosis. J. Bone Miner. Res. 7:1992;1005-1010.
2. Ballard P.A., Purdie D.W., Langton C.M., Steel S.A., Mussurakis S. Prevalence of osteoporosis and related risk factors in UK women in the seventh decade: osteoporosis case finding by clinical referral criteria or predictive model. Osteoporos. Int. 8:1998;535-539.
3. World Health Organisation. Assesment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a World Health Organisation study group. World Health Organ Tech Rep Ser 1994;843:1-129.
4. Lippuner K., Overbeck J., Perrelet R., Bosshard H., Jaeger P. Incidence and direct medical costs of hospitalizations due to osteoporotic fractures in Switzerland. Osteoporos. Int. 7:1997;414-425.
5. Cummings S.R., Bates D., Black D.M. Clinical use of bone densitometry. Scientific review. JAMA. 288:2002;1889-1897.
6. Bates D.W., Black D.M., Cummings S.R. Clinical use of bone densitometry. Clinical applications. JAMA. 288:2002;1898-1900.
7. Freedman K.B., Kaplan F.S., Bilker W.B., Strom B.L., Lowe R.A. Treatment of osteoporosis: are physicians missing opportunity. J. Bone Joint Surg. Am. 82A:2000;1063-1070.
8. Weibel ER. Stereological methods. Practical methods for biological morphometry. London, New York, Toronto, Sydney, San Francisco: Academic Press; 1979. p. 101-61.
9. Riggs B.L., Melton L.J. III The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone. 17(5 Suppl):1995;505S-511S.
10. Compston J.E., Papapoulos S.E., Blanchard F. Report on osteoporosis in the European Community: current status and recommendations for the future. Osteoporos. Int. 8:1998;531-534.
11. Melton L.J. III Epidemiology of spinal osteoporosis. Spine. 22(24 Suppl):1997;2S-11S.
12. American Society of Cytopathology. Cervical cytology practice guideline. Diagn Cytopathol 2001;25(1):3-24.
13. Linos A, Riza E, van Ballegooijen M, editors. Cervical cancer screening in the European Union. Eur J Cancer 2000;36(17 Special Issue):2175-2275.
14. Van der Graaf Y., Vooijs G.P., Zielhuis G.A. Cervical screening revisited. Acta Cytol. 34:1990;366-372.
15. Mandelblatt J.S., Lawrence W.F., Womack S.M., Jacobson D., Yi B., Hwang Y.et al. Benefits and costs of using HPV testing to screen for cervical cancer. JAMA. 287:2002;2372-2381.
16. Kim J.J., Wright T.C., Goldie S.J. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA. 287:2002;2382-2390.
17. Helms L.J., Melnikow J. Determining costs of health care services for cost-effectiveness analyses: the case of cervical cancer prevention and treatment. Med. Care. 37:1999;652-661.
18. Sim M.F., Stone M., Johansen A., Evans W. Cost effectiveness analysis of BMD referral for DXA using ultrasound as a selective pre-screen in a group of women with low trauma Colles' fractures. Technol. Health Care. 8:2000;277-284.
19. Abbott T.A. III, Mucha L., Manfredonia D., Schwartz E.N., Berger M.L. Efficient patient identification strategies for women with osteoporosis. J. Clin. Densitom. 2:1999;223-230.
20. National Osteoporosis Foundation. Physician's guide to prevention and treatment of osteoporosis. Washington, DC: National Osteoporosis Foundation; 1999.